The treatment of androgenpotentiated hair disorders

6.5.1 Androgenetic alopecia

Currently, the most effective treatment for male pattern baldness is the transplant of follicles from non-balding sites into the balding region, capitalising on the retention ofthe different intrinsic responses to androgen discussed earlier. This has significant disadvantages; not only is it very invasive and heavily reliant on the skill of the operator for a good cosmetic result, but the alopecia continues to progress behind the transplanted area so that further transplants are often required.

Antiandrogen therapy is not a practical option for men due to the side-effects, but cyproterone acetate, in combination with estrogen to ensure contraception, has been used in women. It increased the percentage of hair follicles in anagen and may cause some regrowth, but is probably most effective in preventing further progression (Dawber and Van Neste 1995; Peereboom-Wynia et al. 1989). Since cyproterone acetate is unavailable in the USA, spirolactone and high-dose cimeti-dine have been used as alternative antiandrogens.

Minoxidil, a vasodilator used for hypertension, stimulated excessive hair growth as a side-effect. This provoked major interest in hair follicle biology because it demonstrated that vellus follicles could be stimulated to form terminal hairs. Topical application of minoxidil has been used in both male and female androgenetic alopecia. It stimulates regrowth in up to 30% with only about 10% obtaining complete regrowth, probably by acting as a potassium channel regulator; most success occurs with younger men and with the early stages of balding, i.e. Hamilton stage V or less (Dawber and Van Neste 1995). More recently, a stronger topical application of a 5% solution has been licensed for use in men (Olsen etal. 2002).

Finasteride, a 5a-reductase type 2 inhibitor, was developed to treat androgen-potentiated prostate disorders and is now available as an oral treatment for andro-genetic alopecia in men in many countries at a lower dose of 1 mg per day. Clinical trials demonstrated significant effects on stimulating hair regrowth in men with mild to moderate hair loss (Kaufman etal. 1998; Shapiro and Kaufman 2003). Even if hair did not regrow, balding progression was frequently halted. Unfortunately, no effects of finasteride have been seen in post-menopausal women with androge-netic alopecia (Price etal. 2000); use in pre-menopausal women requires ensuring against contraception in case of potential feminisation of a male fetus.

Although a range of treatments are now available, they all need to be used continually because they are opposing a natural process which, if treatment is discontinued, retains all the components to continue to progress.

6.5.2 Hirsutism

Once a serious underlying pathology has been eliminated, a range of treatments is available for hirsutism (Azziz 2003). Cosmetic treatments such as bleaching, depilatory measures such as shaving, waxing, electrolysis or laser are common. Electrolysis with the aim of permanent removal by killing the dermal papilla and germinative epithelium/stem cells is the most established long-lasting treatment, but it is expensive, time consuming and may cause scarring; removal by laser treatment is a more recently introduced alternative (Levy etal. 2001; Sanchez et al. 2002).

The most common endocrine treatment, outside the USA, is the antiandrogen, cyproterone acetate, given with estrogen if the woman is premenopausal; spiro-lactone or flutamide can be used as an alternative (Fruzzetti 1997; Lumachi and Rondinome 2003). Patients have to be well-motivated because hair growth on the face generally takes at least nine months before a noticeable effect occurs, although any acne will be cleared in a couple of months and effects on thigh hair growth will be seen in four to six months (Sawers etal. 1982). Facial responses are seen first on the sides of the face and last on the upper lip, in reverse order to the appearance of facial hair in men (personal observations). Finasteride has also been used for hirsutism with some success (Lacryc etal. 2003). This seems logical as 5a-reductase type 2 is necessary for male pattern body hair growth (see Section 6.4.1). Contraception is still required with all endocrine treatments due to the potential to affect the development of a male fetus. Metformin, insulin-sensitising therapy, aimed to alter the insulin resistance and hence the hyperandrogenism often associated with polycystic ovarian disease has been used clinically, but the evidence has yet to be rigorously tested (Harborne etal. 2003).

Overall, there have been major changes in the treatment of androgen-potentiated disorders over the last ten years. The ideal treatment of a uniformly effective, topical treatment which is inactivated on contact with the blood or is specific for hair follicles is not yet available. Further research on the biology of androgen action in the hair follicle may facilitate its development.

6.6 Key messages

• Androgens are the main regulator of human hair growth.

• Androgens have paradoxically different effects on hair follicles depending on their body site. They can stimulate the formation of large hairs e.g. beard, axilla, have no effect e.g. eyelashes or inhibit follicles on the scalp.

• All effects are gradual.

• Androgen-potentiated disorders of hair growth are common including hirsutism in women and androgenetic alopecia in both sexes.

• Androgen receptors are necessary for all androgen-dependent hair growth and 5a-reductase type 2 for most, but not for female patterns of axillary and pubic hair, even in men.

• The action of androgens on human hair follicles demonstrates several paradoxes: contrasting effects in different sites; major differences in the persistence of stimulatory effects depending on body region; a varying requirement for the formation of 5a-dihydrotestosterone even amongst follicles exhibiting increased growth. Since these are all site-related and retained on transplantation, these indicate intrinsic differences within follicles, presumably determined during embryonic development.

• The current model for androgen action in the hair follicle proposes that androgens act via the cells of the dermal papilla, altering their production of regulatory paracrine factors such as growth factors which then influence the activity of other follicular components, e.g. keratinocytes, melanocytes and endothelial cells. The dermal sheath may also play a role as a direct androgen target.

• Antiandrogens, generally cyproterone acetate, and a 5a-reductase type 2 inhibitor, finasteride, are being used to control androgenetic alopecia and hirsutism.

• Endocrine treatments may need several months to show their effects and will need to be used continually.

• Further understanding of the mechanism of androgens in the hair follicle is necessary to enable the development of better treatments, preferably working topically and specific to the hair follicle.


Ando Y, Yamaguchi Y, Hamada K, Yoshikawa K, Itami S (1999) Expression of mRNA for androgen receptor, 5a-reductase and 17p-hydroxysteroid dehydrogenase in human dermal papilla cells. Br J Derm 141:840-845 Anonymous (1970) Effects of sexual activity on beard growth in men. Nature 226:869-870 Asada Y, Sonoda T, Ojiro M, Kurata S, Sato T, Ezaki T, Takayasu S (2001) 5a-reductase type 2 is constitutively expressed in the dermal papilla and connective tissue sheath of the hair follicle in vivo but not during culture in vitro. J Clin Endocr Metab 86:2875-2880 Azziz R (2003) The evaluation and management of hirsutism. Obstet Gynaecol 101:995-1007 Birch MP, Lalla SC, Messenger AG (2002) Female pattern hair loss. Clin Exp Derm 27:383-388 Bradfield RB (1971) Protein deprivation: comparative response of hair roots, serum protein and urinary nitrogen. Amer J Clin Nutrit 24:405-410 Cash TF (1992) The psychological effects of androgenetic alopecia in men. J Am Acad Derm 26:926-931

Cash TF (1993) Psychological effects of androgenetic alopecia on women: comparisons with balding men and with female control subjects. J Am Acad Derm 29:568-575 Chieffi M (1949) Effect of testosterone administration on the beard growth of elderly males. J Geront 4:200-204

Choudhry R, Hodgins MB, Van Der Kwast TH, Brinkman AO, Boersma, WJA (1992) Localisation ofandrogen receptors in human skin by immunohistochemistry: implications forthehormonal regulation of hair growth, sebaceous glands and sweat glands. J Endocr 133:467-475 Cotsarelis C, Sun T, Lavker R (1990) Label-retaining cells reside in the bulge area ofthe pilose-baceous unit; Implications for follicular stem cells, hair cycle and skin carcinogenesis. Cell 61:1329-1337

Courtois M, Loussouarn G, Hourseau C, Grollier JF (1995) Ageing and hair cycles. Br J Derm 132:86-93

Courtois M, Loussouarn G, Hourseau S, Grollier JF (1996) Periodicity in the growth and shedding of hair. Br J Derm 134:47-54

Cunha GR, Donjacour AA, Cook PS, Mee S, Bigby RH, Higgins S, Sugimura Y (1987) The endocrinology and developmental biology of the prostate. Endocr Rev 8:338-362 Dawber R, Van Neste D (1995) Hair and scalp disorders. Martin Dunitz, London Demark-Wahnefried W, Lesko SM, Conaway MR, Robertson CN, Clark RV, Lobaugh B, Mathias BJ, Strigo TS, Paulsa DF (1997) Serum androgens: associations with prostate cancer risk and hair patterning. J Androl 18:495-500 Ebling FJG (1985) Age changes in cutaneous appendages. J Appl Cosmet 3:342-250 Ebling FJG, Johnson E (1959) Hair growth and its relation to vascular supply in rotated skin grafts and transposed flaps in the albino rat. J Embry Exp Morph 9:285-293 Ebling FJG, Hale PA, Randall VA (1991) Hormones and hair growth. In: Goldsmith LA (ed)

Biochemistry and physiology of the skin, Second ed Clarenden Press, Oxford pp 660-696 Ellis JA, Stebbing M, Harrap SB (2001) Polymorphism of androgen receptor gene is associated with male pattern baldness. J Invest Derm 116:452-455 Elliot K, Stephenson TJ, Messenger AG (1999) Differences in hair follicle dermal papilla volume are due to extracellular matrix volume and cell number: implications for the control of hair follicle size and androgen responses. J Invest Derm 113:873-877 Ferriman D, Gallwey JD (1961) Clinical assessment of body hair growth in women. J Clin Endocr Metab 21:1440-1447

Flux JEC (1970) Colour change of mountain hares (lepustimidusscoticus) in north-east Scotland. Zool 162:345-358

Franzoi SL, Anderson J, Frommelt S (1999) Individual difference in men's perceptions of and reactions to thinning hair. J Soc Psychol 130:209-218 Fruzetti F (1997) Treatment of hirsutism: antiandrogen and 5a-reductase inhibitor therapy. In: Azziz R, Nestler JE, Dewailly D (eds) Androgen excess disorders in women. Lippincott-Raven, Philadelphia pp 787-797 Girman CJ, Rhodes T, Lilly FRW, Guo SS, Siervogal RM, Patrick DL, Chumlea WC (1998) Effects of self-perceived hair loss in a community sample of men. Dermatology 197:223-229 Goodhart CB (1960) The evolutionary significance of human hair patterns and skin colouring. Adv Sci 17:53-58

Griffin JE, Wilson JD (1989) The resistance syndromes: 5a-reductase deficiency, testicular feminisation and related disorders. In: Baudet AL, Sly WS, Valle D (eds) The metabolic basis of inherited disease. ScriverCR, McGraw-Hill, New York pp 1919-1944 Hamada K, Randall VA (2003) Balding scalp dermal papilla cells secrete a soluble factor(s) which delays the onset of anagen in mice in vivo. J Invest Derm Symp Proc 8:139 Hamada K, Thornton MJ, Liang I, Messenger AG, Randall VA (1996) Pubic and axillary dermal papilla cells do not produce 5a-dihydrotestosterone in culture. J Invest Derm 106:1017-1022 Hamilton JB (1942) Male hormone stimulation is a prerequisite and an incitant in common baldness. Amer J Anat 71:451-480 Hamilton JB (1946) A secondary sexual character that develops in men but not in women upon aging of an organ present in both sexes. Anat Rec 94:466-467 Hamilton JB (1951a) Quantitative measurement of a secondary sex character and axillary hair. Ann N Y Acad Sci 53:585-599

Hamilton JB (1951b) Patterned loss of hair in man; types and incidence. Ann N Y Acad Sci 53:708-728

Hamilton JB (1958) Age, sex and genetic factors in the regulation of hair growth in man: a comparison of Caucasian & Japanese populations. In: Montagna W, Ellis RA (eds) The biology of hair growth. Academic Press, New York pp 399-433 Harborne L, Fleming R, Lyall H, Norman J, Sattar N (2003) Descriptive review of the evidence for the use of metformin in polycystic ovary syndrome. Lancet 361:1894-1901 Hibberts NA, Randall VA (1996) Testosterone inhibits the capacity of cultured balding scalp dermal papilla cells to produce keratinocyte mitogenic factors. In: Van Neste D, Randall VA (eds) Hair research for the next millennium. Elsevier Science, Amsterdam pp 303-306 Hibberts NA, Messenger AG, Randall VA (1996a) Dermal papilla cells derived from beard hair follicles secrete more stem cell factor (SCF) in culture than scalp cells or dermal fibroblasts. Biochem Biophys Res Commun 222:401-405 Hibberts NA, Sato K, Messenger AG, Randall VA (1996b) Dermal papilla cells from human hair follicles secrete factors (eg VEGF) mitogenic for endothelial cells. J Invest Derm 106:341 Hibberts NA, Howell AE, Randall VA (1998) Dermal papilla cells from human balding scalp hair follicles contain higher levels of androgen receptors than those from non-balding scalp. J Endocr 156:59-65

Ibanez L, Ong KK, Mongan N, Jaaskelainen J, Marcos MV, Hughes IA, De Zegher F, Dunger DB (2003) Androgen receptor gene CAG repeat polymorphism in the development of ovarian hyperandrogenism. J Clin Endocr Metab 88:3333-3338 Imperato-McGinley J, Gautier T, Cai L, Yee B, Epstein J, Pochi P (1993) The androgen control of sebum production. Studies of subjects with dihydrotestosterone deficiency and complete androgen insensitivity. J Clin Endocr Metab 76:524-528 Inui S, Itami S, Pan HJ, Chang C (2000) Lack of androgen receptor transcriptional activity in human keratinocytes lack of AR activity in Ha CaT keratinocytes. J Derm Sci 23:87-99 Itami S, Kurata S, Takayasu S (1990) 5a-reductase activity in cultured human dermal papilla cells from beard compared with reticular dermal fibroblasts. J Invest Derm 94:150-152 Itami S, Kurata S, Sonada T, Takayasu S (1995a) Interactions between dermal papilla cells and follicular epithelial cells in vitro: effect of androgen. Br J Derm 132:527-532 Itami S, Kurata S, Takayasu S (1995b) Androgen induction of follicular epithelial cell growth is mediated via insulin-like growth factor I from dermal papilla cells. Biochem Biophys Res Commun 212:988-994

Jackson D, Church RE, Ebling FJG (1972) Hair diameter in female baldness. Br J Derm 87:361367

JahodaCAB, Reynolds AJ (1996) Dermal-epidermal interactions; adult follicle-derived cell populations and hair growth. In: Whiting DA (ed) Derm clinics 14. Update on hair disorders. WB Saunders, Philadelphia pp 573-583 Jahoda CAB, Horne KA, Oliver RF (1984) Induction of hair growth by implantation of cultured dermal papilla cells. Nature 311:560-562 Jenkins JS, Ash S (1973) The metabolism of testosterone by human skin in disorders of hair growth. J Endocr 59:345-351

Kaufman KD, Olsen EA, Whiting D, Savi R, De Villez R, Bergfeld W and the Finasteride Male Pattern Hair Loss Study Group (1998) Finasteride in the treatment of men with androgenetic alopecia. J Am Acad Derm 39:578-589 Kligman AM (1959) The human hair cycle. J Invest Derm 33:307-316

Kligman AM (1988) The comparative histopathology of male-pattern baldness and senescent baldness. Clin Derm 6:108-118 Lakryc EM, Motta EL, Soares JM Jr., Haider MA, de Lima GR, Baracat EC (2003) The benefits of finasteride for hirsute women with polycystic ovary syndrome or idiopathic hirsutism. Gynaecol Endocr 17:57-63 Lavker RM, Sun TT, Oshima H, Barrandon Y, Akiyama M, Ferraris C, Chevalier G, Favier B, Jahoda CAB, Dhouailly D, Panteleyer AA, Christiano AM (2003) Hair follicle stem cells. J Invest Derm Symp Proc 8:28-38 Lesko SM, Rosenberg L, Shapiro S (1993) Acase-control studyofbaldness in relation to myocardial infarction in men. J Amer Med Ass 269:998-1003 Levy JL, Trelles MA, de Ramecourt A (2001) Epilation with a long-pulse 1064 nm Nd: YAG laser in facial hirsutism. J Cosmet Laser Ther 3:175-179 Ludwig E (1977) Classification of the types of androgenetic alopecia (common baldness) occurring in the female sex. Br J Derm 97:247-254 Lumachi F, Rondinone R (2003) Use of cyproterone acetate, finasteride, and spirolactone to treat idiopathic hirsutism. Fertil Steril 79:942-946 Lynfield YL (1960) Effect of pregnancy on the human hair cycle. J Invest Derm 35:323-327 Maffei C, Fossati A, Reialdi F, Ruia E (1990) Personality disorders andpsychopathologic symptons in patients with androgenetic alopecia. Arch Derm 130:868-872 Marshall WA, Tanner JM (1969) Variations in pattern of pubertal change in girls. Arch Dis Child 44:291-303

Marshall WA, Tanner JM (1970) Variations in the pattern of pubertal changes in boys. Arch Dis Child 45:13-23

Merrick AE, Randall VA, Messenger AG, Thornton MJ (2004) Beard dermal sheath cells contain androgen receptors: implications for future inductions of human hair follicles. J Invest Derm (submitted)

Messenger AG, Elliott K, Temple A, Randall VA (1991) Expression of basement membrane proteins and interstitial collagens in dermal papillae ofhuman hair follicles. J Invest Derm 96:93-97 Norwood OT (1975) Male pattern baldness, classification and incidence. South Med J 68:13591365

Obana N, Chang C, Uno H (1997) Inhibition of hair growth by testosterone in the presence of dermal papilla cells from the frontal bald scalp of the post-pubertal stump-tailed macaque. Endocrinology 138:356-361 Olsen EA, Dunlap FE, Funicella T, Koperski JA, Swinehart JM, Tschen EH, Trancik RJ (2002) A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men. J Am Acad Derm 47:377-85 Orentreich N (1969) Scalp hair replacement in man. In: Montagna W, Dobson RL (eds) Adv Biol

Skin Vol 9. Hair growth. Pergamon Press, Oxford pp 99-108 Orentreich N, Durr NP (1982) Biology of scalp hair growth. Clin Plas Surg 9:197-205

Pantelevev AA, Jahoda CAB, Christiano AM (2001) Hair follicle predetermination. J Cell Sci 114:3419-3431

Paus R, Müller-Rover S, McKay I (2000) Control of the hair follicle growth cycle. In: Camacho FM, Randall VA, Price VH (eds) Hair and its disorders: Biology, pathology and management. Martin Dunitz, London pp 83-94 Peereboom-Wynia JDR, Van Der Willigen AH, Stolz E, Van Joost TH (1989) The effect of cypro-terone acetate on hair roots and hair shaft diameter in androgenetic alopecia in females In: Van Neste D, Lachapelle JM, Antoine JL (eds) Trends in human hair growth and alopecia research. Kluwer, Dordrecht pp 207-213 Philpott MP (2000) The roles of growth factors in hair follicles: investigations using cultured hair follicles. In: Camacho F, Randall VA, Price VH (eds) Hair and its disorders: Biology, research and management, Martin Dunitz, London pp 103-113 Price VH, Roberts JL, Hordinsky M, Olsen EA, Savin R, Bergfeld W, Fiedler V, Lucky A, Whiting DA, Pappas F, Culbertson J, Kotey P, Meehan A, Waldstreicher J (2000) Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia. J Am Acad Derm 43:768-76

Randall VA (1994a) Androgens and human hair growth. Clin Endocr 40:439-457 Randall VA (1994b) The role of 5a-reductase in health and disease. In: Sheppard M, Stewart P (eds) Hormones, enzymes and receptors. Bailliére's clinical endocrinology and metabolism 8:vol 2:405-431

Randall VA (2000a) The biology of androgenetic alopecia. In: Camacho F, Randall VA, Price VH (eds) Hair and its disorders: Biology, research and management, Martin Dunitz, London pp 123-136

Randall VA (2000b) Androgens: the main regulator ofhuman hair growth. In: Camacho F, Randall VA, Price VH (eds) Hair and its disorders: Biology, research and management, Martin Dunitz, London pp 69-82

Randall VA (2003) Biological effects of androgens on the hair follicle: experimental approaches.

In: Van Neste D (ed) Hair science and technology, Brussels pp 75-92 Randall VA (2004) Physiology and pathophysiology of androgenetic alopecia. In: Degroot LJ,

Jameson JL (eds). Endocrinology 5th ed WB Saunders Co Philadelphia (in press) Randall VA, Ebling FJG (1991) Seasonal changes in human hair growth. Br J Derm 124: 146-151

Randall VA, Hibberts NA, Thornton MJ, Merrick AE, Hamada K, Kato S, Jenner TJ, De Oliveira I, Messenger AG (2001a) Do androgens influence hair growth by altering the paracrine factors secreted by dermal papilla cells? Eur J Derm 11:315-320 Randall VA, Hibberts NA, Thornton MJ, Hamada K, Merrick AE, Kato S, Jenner TJ, De Oliveria I, Messenger AG (2001b) The hair follicle: a paradoxical androgen target organ. Horm Res 54:243-250

Randall VA, Sundberg JP, Philpott MP (2003) Animal and in vitro models for the study of hair follicles. J Invest Derm Symp Proc 8:39-45 Randall VA, Thornton MJ, Hamada K, Redfern CPF, Nutbrown M, Ebling FJG, Messenger AG (1991) Androgens and the hair follicle: cultured human dermal papilla cells as a model system. Ann N Y Acad Sci 642:355-375

Randall VA, Thornton MJ, Messenger AG (1992) Cultured dermal papilla cells from androgen-dependent human follicles (e.g. beard) contain more androgen receptors than those from non-balding areas. J Endocr 133:141-147 Reynolds AJ, Lawrence C, Cserhalmi-Friedman PB, Christiano AM, Jahoda CAB (1999) Trans-

gender induction of hair follicles. Nature 402:33-34 Saitoh M, Sakamoto M (1970) Human hair cycle. J Invest Derm 54:65-81 Sanchez LA, Perez M, Azziz R (2002) Laser hair reduction in the hirsute patient: a critical assessment. Hum Reprod Update 8:169-181 SawersRA, Randall VA, IqbalMJ (1982) Studies on the clinical and endocrine aspects ofantiandro-gens. In: Jeffcoate SL (ed) Androgens and antiandrogen therapy. Current topics in endocrinology. John Wiley, Chichester pp 145-168 Setty LR (1970) Hair patterns of the scalp of white and negro males. Amer J Phys Anthrop 33:49-55

Shapiro J, Kaufman KD (2003) Use of finasteride in the treatment of men with androgenetic alopecia (male pattern hair loss). J Invest Derm Symp Proc 8:20-23 Sonada T, Asada Y, Kurata S, Takayasu S (1999) The mRNA for protease nexin-1 is expressed in human dermal papilla cells and its level is affected by androgen. J Invest Derm 113:308-313 Stanford JL, Just JJ, Gibbs M, Wicklund KG, Neal CL, Blumenstein BA, Ostrander EA (1997) Polymorphic repeats in the androgen receptor gene: molecular markers of prostate cancer risk. Cancer Res 57:1194-1198 Stenn K, Parimoo S, Prouty S (1998) Growth of the hair follicle: a cycling and regenerating biological system. In: ChuongCM (ed) Molecular basis of epithelial appendage morphogenesis. Laudes, Austin, Texas

Taylor G, Lehrer MS, Jensen PJ, Sun TT, Lavker RM (2000) Involvement of follicular stem cells in forming not only the follicle but also the epidermis. Cell 102:451-461 Terry RL, Davis JS (1976) Components of facial attractiveness. Percept Motor Skills 42:918-923 Thornton MJ, Laing I, Hamada K, Messenger AG, Randall VA (1993) Differences in testosterone metabolism by beard and scalp hair follicle dermal papilla cells. Clin Endocr 39:633-639 Thornton MJ, Hamada K, Messenger AG, Randall VA (1998) Beard, but not scalp, dermal papilla cells secrete autocrine growth factors in response to testosterone in vitro. J Invest Derm 111:727732

TsujiY, DendaS, SomaT, Raferty L, MomoiT, Hibino T (2003) A potential suppressor of TGF-ß

delays catagen progression in hair follicles. J Invest Derm Symp Proc 8:65-68 Van der Dank J, Passchier J, Knegt-Junk C, Wegen-Keijser MH, Nieboer C, Stolz E, Verhage F (1991) Psychological characteristics of women with androgenetic alopecia: a controlled study. Br J Derm 125:248-252

Venning VA, Dawber R (1988) Patterned androgenic alopecia. J Amer Acad Derm 18:1073-1077 Wells PA, Willmoth T, Russel RJH (1995) Does fortune favour the bald? Psychological correlates of hair loss in males. Br J Psychol 86:337-344 Winter JSD, Faiman C (1972) Pituitary-gonadal relations in male children and adolescents. Paed Res 6:125-135

Winter JSD, Faiman C (1973) Pituitary-gonadal relations in female children and adolescents. Paed Res 7:948-953

Wu-Kuo T, Chuong C-M (2000) Developmental biology of hair follicles and other skin appendages. In: Camacho FM, Randall VA, Price VH (eds) Hair and its disorders: Biology, pathology and management. Martin Dunitz, London pp 17-37 Zachmann M, Prader A (1970) Anabolic and androgenetic effect of testosterone in sexually immature boys and its dependency on GH. J Clin Endocr Metab 30:85-95 Zachmann M, Aynsley-Green A, Prader A (1976) Interrelations of the effects of growth hormone and testosterone in hypopituitarism. In: Pecile A, MullerEE (eds) Growth hormone and related peptides. Excerpta Medica, Amsterdam and Oxford pp 286-296

Diabetes 2

Diabetes 2

Diabetes is a disease that affects the way your body uses food. Normally, your body converts sugars, starches and other foods into a form of sugar called glucose. Your body uses glucose for fuel. The cells receive the glucose through the bloodstream. They then use insulin a hormone made by the pancreas to absorb the glucose, convert it into energy, and either use it or store it for later use. Learn more...

Get My Free Ebook

Post a comment